Loading...
A phase II study of bortezomib in patients with MALT lymphoma
We have performed a phase II study to evaluate bortezomib in patients with MALT-lymphoma. Sixteen patients entered the trial, 4 had gastric MALT-lymphoma, 7 of the ocular adnexa, one of the colon, and 2 of the parotid, and one patient each the lung and the breast. Bortezomib was given at 1.5 mg/m(2)...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ferrata Storti Foundation
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2675689/ https://ncbi.nlm.nih.gov/pubmed/19336742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2008.001537 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|